Refine Your Results

Click below to filter your search results

"Guidelines"Undo

Search Results

Return to List
Results 141–160 of 214
Title Date
141.

Choosing the Route of Hysterectomy for Benign Disease

Number 444

(Reaffirmed 2011)

ABSTRACT: Hysterectomies are performed vaginally, abdominally, or with laparoscopic or robotic assistance. When choosing the route and method of hysterectomy, the physician should take into consideration how the procedure may be performed most safely and cost-effectively to fulfill the medical nee...

November 2009

PDF Format
142.

Air Travel During Pregnancy

Number 443

(Replaces No. 264, December 2001)

ABSTRACT: In the absence of obstetric or medical complications, pregnant women can observe the same precautions for air travel as the general population and can fly safely. Pregnant women should be instructed to continuously use their seat belts while seated, as should all air travelers. Pregnant ...

October 2009

PDF Format
143.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT: Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish (Ashkenazi) descent. Previously, the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screeni...

October 2009

PDF Format
144.

Oral Intake During Labor

Number 441

(Reaffirmed 2013)

ABSTRACT: There is insufficient evidence to address the safety of any particular fasting period for solids in obstetric patients. Expert opinion supports that patients undergoing either elective cesarean delivery or elective postpartum tubal ligation should undergo a fasting period of 6–8 hours. A...

September 2009

PDF Format
145.

The Role of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding

Number 440

(Reaffirmed 2013)

ABSTRACT: The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose carcinoma. Women with postmenopausal bleeding may be assessed initially with either endometrial biopsy or transvaginal ultrasonography; this initial evaluation does not requir...

August 2009

PDF Format
146.

Informed Consent

Number 439

(Reaffirmed 2012)

ABSTRACT: Obtaining informed consent for medical treatment, for participation in medical research, and for participation in teaching exercises involving students and residents is an ethical requirement that is partially reflected in legal doctrines and requirements. As an ethical doctrine, informe...

August 2009

PDF Format
147.

Community Involvement and Volunteerism

Number 437

(Reaffirmed 2014)

ABSTRACT: As professional and community leaders, obstetrician–gynecologists have unlimited opportunities to become involved in and have a positive impact on local, national, and international communities and organizations. Volunteering outside of daily work routines often revitalizes a commitment ...

July 2009

PDF Format
148.

Induced Abortion and Breast Cancer Risk

Number 434

(Reaffirmed 2013, Replaces No. 285, August 2003)

ABSTRACT: The relationship between induced abortion and the subsequent development of breast cancer has been the subject of a substantial amount of epidemiologic study. Early studies of the relationship between prior induced abortion and breast cancer risk were methodologically flawed. More rigoro...

June 2009

PDF Format
149.

Optimal Goals for Anesthesia Care in Obstetrics

Number 433

(Replaces No. 256, May 2001)

ABSTRACT: A joint statement from the American Society of Anesthesiologists and the American College of Obstetricians and Gynecologists was developed to address issues of concern to both specialties. Good obstetric care requires the availability of qualified personnel and equipment to administer ge...

May 2009

PDF Format
150.

Spinal Muscular Atrophy

Number 432

ABSTRACT: Spinal muscular atrophy (SMA) is an autosomal recessive neurodegenerative disease that results from degeneration of spinal cord motor neurons leading to atrophy of skeletal muscle and overall weakness. In current practice, patients with a family history of SMA are being offered carrier s...

May 2009

PDF Format
151.

Preimplantation Genetic Screening for Aneuploidy

Number 430

(Reaffirmed 2014)

ABSTRACT: Preimplantation genetic screening differs from preimplantation genetic diagnosis for single gene disorders and was introduced for the detection of chromosomal aneuploidy. Current data does not support a recommendation for preimplantation genetic screening for aneuploidy using fluorescenc...

March 2009

PDF Format
152.

Misoprostol for Postabortion Care

Number 427

ABSTRACT: The World Health Organization estimates that 67,000 women, mostly in developing countries, die each year from untreated or inadequately treated abortion complications. Postabortion care, a term commonly used by the international reproductive health community, refers to a specific set of ...

February 2009

PDF Format
153.

Health Care for Undocumented Immigrants

Number 425

ABSTRACT: Undocumented immigrants are less likely than other residents of the United States to have health insurance. Their access to publicly funded health programs has become increasingly limited since the passage of welfare reform in 1996 and varies from state to state. This is reflected in les...

January 2009

PDF Format
154.

Motivational Interviewing: A Tool for Behavior Change

Number 423

(Reaffirmed 2014)

ABSTRACT: Applying the principles of motivational interviewing to everyday patient interactions has been proved effective in eliciting "behavior change" that contributes to positive health outcomes and improved patient–physician communication. Current Procedural Terminology codes are available to ...

January 2009

PDF Format
155.

At-Risk Drinking and Illicit Drug Use Ethical Issues in Obstetric and Gynecologic Practice

Number 422

(Replaces No. 294, May 2004)

ABSTRACT: Drug and alcohol abuse is a major health problem for American women regardless of their socioeconomic status, race, ethnicity, and age. It is costly to individuals and to society. Obstetrician–gynecologists have an ethical obligation to learn and use a protocol for universal screening qu...

December 2008

PDF Format
156.

Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

Number 418

(Reaffirmed 2011, Replaces No. 304, November 2004)

ABSTRACT: Early identification and treatment of all pregnant women with human immunodeficiency virus (HIV) is the best way to prevent neonatal disease and improve the woman's health. Human immunodeficiency virus screening is recommended for all pregnant women after they are notified that they will...

September 2008

PDF Format
157.

The Uninsured

Number 416

(Replaces No. 308, December 2004)

ABSTRACT: The United States is one of the few industrialized nations in the world that do not guarantee health care for their populations. Access to health care for all women is of paramount concern to obstetrician–gynecologists and the American College of Obstetricians and Gynecologists. Pregnant...

September 2008

PDF Format
158.

Aromatase Inhibitors in Gynecologic Practice

Number 412

(Reaffirmed 2012)

ABSTRACT: Aromatase inhibitors appear to be effective as an adjuvant treatment for early-stage and late-stage breast cancer. Their role in chemoprevention of breast cancer in high-risk patients remains to be defined. Side effects of aromatase inhibitors in postmenopausal women are due to estrogen-...

August 2008

PDF Format
159.

Ethical Issues in Genetic Testing

Number 410

ABSTRACT: Genetic testing is poised to play an increasing role in the practice of obstetrics and gynecology. To assure patients of the highest quality of care, physicians should become familiar with the currently available array of genetic tests and the tests' limitations. Clinicians should be abl...

June 2008

PDF Format
160.

Direct-to-Consumer Marketing of Genetic Testing

Number 409

ABSTRACT: Marketing of genetic testing, although similar to direct-to-consumer advertising of prescription drugs, raises additional concerns and considerations. These include issues of limited knowledge among patients and health care providers of available genetic tests, difficulty in interpretati...

June 2008

PDF Format